Rheumatoid Arthritis Resource Center
The Great Debate at ACR Convergence 2020 is: Janus Kinase Inhibitors Should/Should Not Be Used Before Biologics After Methotrexate Failure in RA. No need to hang in suspense. In this resource center, you’ll get the pros and cons, and highlights from other important sessions on rheumatoid arthritis (RA). Plus, you can explore our collection of research reviews, case reports and clinical articles on advances in the diagnosis and management of RA.
VIEW
Highlights, Pearls & News from ACR Convergence 2020
Micromotors Promising for Rheumatoid Arthritis Therapy
Study Explores Palindromic Rheumatism to Predict RA Development
Modern Treatment Tied to Low Disease Activity in Pregnant RA Patients
A High HAQ at Baseline in Early RA Is a Bad Sign
Researchers Propose a Sensitive, Specific Biomarker for Rheumatoid Arthritis
A Closer Look at Antibodies in RA: How Anti-Citrullinated Protein Antibodies, Anti-Modified Protein Autoantibodies & Rheumatoid Factor Activity Overlap
Coronary Microvascular Dysfunction May Predict Heart Disease in Rheumatoid Arthritis
Study Probes Utility of Neutrophil Biomarkers in Rheumatoid Arthritis
- 1
- 2
- 3
- …
- 63
- Next Page »